Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-023975
Filing Date
2021-02-16
Accepted
2021-02-16 16:10:46
Documents
2
Group Members
BRIAN D. GROSSMANPARTNER ASSET MANAGEMENT, LLCPFM HEALTH SCIENCES GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm216018d3_sc13ga.htm SC 13G/A 113212
2 EXHIBIT 99.1 tm216018d3_ex99-1.htm EX-99.1 13156
  Complete submission text file 0001104659-21-023975.txt   128090
Mailing Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111
Business Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111 415-281-1022
PFM Health Sciences, LP (Filed by) CIK: 0001442756 (see all company filings)

EIN.: 262000428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Subject) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90423 | Film No.: 21638402
SIC: 2834 Pharmaceutical Preparations